CRISPR, mRNA and Oligonucleotide experts rarely have the opportunity to come together in one forum to learn from each other and share ideas, because they often attend conferences focused only on their specific molecule. This year's TIDES meeting, held April 30 - May 3, 2017 in San Diego, gathers developers of mRNA, CRISPR and Oligonucleotide therapeutics to discuss common and unique challenges of these complex therapeutics and potential solutions to accelerate product development

Reserve your seat to attend TIDES 2017 to hear case studies and new data designed to help you:

• Accelerate discovery and development efforts by understanding how mRNA, CRISPR and oligonucleotide technologies can be integrated and leveraged together.
• Overcome common discovery and CMC challenges of mRNA, CRISPR and oligonucleotide therapeutics to advance your molecules through the pipeline.
• Cross-fertilize ideas and best practices with CMOs and service providers who offer discovery, CMC and manufacturing services to the mRNA, CRISPR and Oligonucleotide communities.
• Learn about key industry developments in mRNA therapeutics, CRISPR as a discovery tool, and CRISPR as a therapeutic modality.